Summary: Researchers unmasked an alternative biological pathway explaining how GLP-1 receptor agonist medications alleviate ...
G protein-coupled receptors (GPCRs) represent the largest family of membrane proteins and one of the most successful therapeutic targets in modern medicine, with approximately 34% of FDA-approved ...
Drug discovery is shifting from static snapshots to moving pictures. Instead of inferring how medicines work from end results, researchers are now watching individual molecules collide with cell ...
Adenosine A 2A receptors (A 2A R) in the nucleus accumbens of the brain play an important role in regulating sleep and motivation, but until now, no drugs have been able to selectively modulate their ...
Amylin, a hormone that controls appetite and blood sugar by activating three different receptors in the brain, could be the basis for the next blockbuster obesity drugs. A University of Oklahoma study ...
Amylin, a hormone that controls appetite and blood sugar by activating three different receptors in the brain, could be the basis for the next blockbuster obesity drugs. A University of Oklahoma study ...
A recent study published in Engineering delves into the complex mechanisms of drug addiction, highlighting the crucial role of astrocytic G protein-coupled receptors (GPCRs). This research offers ...
Eli Lilly just released impressive study results for retatrutide, an investigational weight loss drug that targets three ...
For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results